Stock Based Compensation	9 Months Ended
Oct. 01, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation	8. Stock Based Compensation During the quarter and nine months ended October 1, 2021, the Company issued 14,357 and 482,031 restricted stock units at a weighted average grant-date fair value of $18.15 and $14.70 per share, respectively. As of October 1, 2021, the Company had 1,196,952 restricted stock units outstanding at a weighted average grant-date fair value of $15.75 per share. As of October 1, 2021, $10.9 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.2 years. As of October 1, 2021, the Company had 12,866 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $16.17 per share. As of October 1, 2021, $61 thousand of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.3 years. Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.

Stock Based Compensation

9 Months Ended

Oct. 01, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

8. Stock Based Compensation

During the quarter and nine months ended October 1, 2021, the Company issued 14,357 and 482,031 restricted stock units at a weighted average grant-date fair value of $18.15 and $14.70 per share, respectively. As of October 1, 2021, the Company had 1,196,952 restricted stock units outstanding at a weighted average grant-date fair value of $15.75 per share. As of October 1, 2021, $10.9 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.2 years.

As of October 1, 2021, the Company had 12,866 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $16.17 per share. As of October 1, 2021, $61 thousand of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.3 years.

Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.